-
AbbVie Inc. (ABBV $216.15)
- $216.15 P/E (TTM): 163.39X Cap: $382.02B
- View ABBV Profile
- View Questions on ABBV
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Intuitive Surgical Inc. (ISRG $523.69)
- $523.69 P/E (TTM): 69.68X Cap: $185.64B
- View ISRG Profile
- View Questions on ISRG
-
Vertex Pharmaceuticals Incorporated (VRTX $461.14)
- $461.14 P/E (TTM): 30.91X Cap: $112.16B
- View VRTX Profile
- View Questions on VRTX
-
AbbVie Inc. (ABBV $216.15)
- $216.15 P/E (TTM): 163.39X Cap: $382.02B
- View ABBV Profile
- View Questions on ABBV
-
Johnson & Johnson (JNJ $218.01)
- $218.01 P/E (TTM): 21.06X Cap: $525.73B
- View JNJ Profile
- View Questions on JNJ
-
Eli Lilly and Company (LLY $1,078.52)
- $1,078.52 P/E (TTM): 50.94X Cap: $1.01T
- View LLY Profile
- View Questions on LLY
-
Merck & Company Inc. (MRK $111.11)
- $111.11 P/E (TTM): 14.47X Cap: $271.65B
- View MRK Profile
- View Questions on MRK
-
iShares Biotechnology ETF (IBB $175.16)
- $175.16 P/E (TTM): 21.3X Cap: $8.75B
- View IBB Profile
- View Questions on IBB
-
IDEXX Laboratories Inc. (IDXX $696.46)
- $696.46 P/E (TTM): 54.4X Cap: $55.61B
- View IDXX Profile
- View Questions on IDXX
-
Halozyme Therapeutics Inc. (HALO $71.71)
- $71.71 P/E (TTM): 16.12X Cap: $8.43B
- View HALO Profile
- View Questions on HALO
-
Incyte Corporation (INCY $104.67)
- $104.67 P/E (TTM): 17.54X Cap: $20.54B
- View INCY Profile
- View Questions on INCY
-
Catalyst Pharmaceuticals Inc. (CPRX $24.13)
- $24.13 P/E (TTM): 13.59X Cap: $2.87B
- View CPRX Profile
- View Questions on CPRX
-
Gilead Sciences CDR (CAD Hedged) (GILD $26.44)
- $26.44 P/E (TTM): 328.71X Cap: $210.04B
- View GILD Profile
- View Questions on GILD
Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare
-
Alphabet Inc. (GOOG $328.38)
- $328.38 P/E (TTM): 31.8X Cap: $3.96T
- View GOOG Profile
- View Questions on GOOG
-
Intuitive Surgical Inc. (ISRG $523.69)
- $523.69 P/E (TTM): 69.68X Cap: $185.64B
- View ISRG Profile
- View Questions on ISRG
-
Booking Holdings Inc. (BKNG $5,163.61)
- $5,163.61 P/E (TTM): 32.75X Cap: $166.44B
- View BKNG Profile
- View Questions on BKNG
-
QUALCOMM Incorporated (QCOM $156.37)
- $156.37 P/E (TTM): 30.75X Cap: $167.47B
- View QCOM Profile
- View Questions on QCOM
-
AbbVie Inc. (ABBV $216.15)
- $216.15 P/E (TTM): 163.39X Cap: $382.02B
- View ABBV Profile
- View Questions on ABBV
-
McDonald's Corporation (MCD $305.69)
- $305.69 P/E (TTM): 25.84X Cap: $215.66B
- View MCD Profile
- View Questions on MCD
-
Altria Group Inc. (MO $61.08)
- $61.08 P/E (TTM): 11.67X Cap: $102.65B
- View MO Profile
- View Questions on MO
-
PepsiCo Inc. (PEP $146.74)
- $146.74 P/E (TTM): 28.07X Cap: $201.90B
- View PEP Profile
- View Questions on PEP
-
Procter & Gamble Company (The) (PG $146.06)
- $146.06 P/E (TTM): 21.46X Cap: $341.30B
- View PG Profile
- View Questions on PG
-
Prudential Financial Inc. (PRU $109.49)
- $109.49 P/E (TTM): 14.82X Cap: $42.22B
- View PRU Profile
- View Questions on PRU
-
United Rentals Inc. (URI $940.09)
- $940.09 P/E (TTM): 23.46X Cap: $57.93B
- View URI Profile
- View Questions on URI
-
Royal Bank of Canada (RY $232.31)
- $232.31 P/E (TTM): 16.08X Cap: $324.70B
- View RY Profile
- View Questions on RY
-
Constellation Software Inc. (CSU $2,706.89)
- $2,706.89 P/E (TTM): 61.05X Cap: $57.36B
- View CSU Profile
- View Questions on CSU
- View Reports on CSU
-
WSP Global Inc. (WSP $268.20)
- $268.20 P/E (TTM): 39.91X Cap: $35.02B
- View WSP Profile
- View Questions on WSP
- View Reports on WSP
-
Thomson Reuters Corporation (TRI $166.14)
- $166.14 P/E (TTM): 30.91X Cap: $73.90B
- View TRI Profile
- View Questions on TRI
-
Shopify Inc. Class A Subordinate Voting Shares (SHOP $191.58)
- $191.58 P/E (TTM): 107.3X Cap: $249.29B
- View SHOP Profile
- View Questions on SHOP
- View Reports on SHOP
-
Nutrien Ltd. (NTR $95.02)
- $95.02 P/E (TTM): 54.34X Cap: $45.92B
- View NTR Profile
- View Questions on NTR
-
Axon Enterprise Inc. (AXON $610.25)
- $610.25 P/E (TTM): 196.74X Cap: $48.44B
- View AXON Profile
- View Questions on AXON
-
EnerSys (ENS $173.80)
- $173.80 P/E (TTM): 19.7X Cap: $6.41B
- View ENS Profile
- View Questions on ENS
-
Berkshire Hathaway Inc. (BRK.B $483.83)
- $483.83 P/E (TTM): 15.52X Cap: $1.04T
- View BRK.B Profile
- View Questions on BRK.B
-
Trane Technologies plc (TT $395.33)
- $395.33 P/E (TTM): 29.82X Cap: $87.66B
- View TT Profile
- View Questions on TT
Q: I’m doing a fairly major portfolio clean-up and account optimization exercise.
Specifically, I’m removing dividend-oriented and income-generating stocks from my TFSA and RRSP that are better suited to a non-registered account, and reallocating TFSA/RRSP capital to assets that benefit most from tax sheltering.
At a broad level, I’d appreciate your perspective on:
• Which CAD and USD names are best suited to an RRSP (e.g., U.S. dividend payers, global compounders, cyclicals, etc.)
• Which CAD and USD names are best suited to a TFSA (long-term growth, compounding, low income leakage)
I’m less interested in yield optimization and more focused on long-term after-tax efficiency and proper account placement.
If helpful, feel free to answer at a category level (e.g., “U.S. dividend aristocrats,” “Canadian compounders,” etc.) or with specific examples you think are particularly well-suited.
Thanks — looking forward to your thoughts.
Specifically, I’m removing dividend-oriented and income-generating stocks from my TFSA and RRSP that are better suited to a non-registered account, and reallocating TFSA/RRSP capital to assets that benefit most from tax sheltering.
At a broad level, I’d appreciate your perspective on:
• Which CAD and USD names are best suited to an RRSP (e.g., U.S. dividend payers, global compounders, cyclicals, etc.)
• Which CAD and USD names are best suited to a TFSA (long-term growth, compounding, low income leakage)
I’m less interested in yield optimization and more focused on long-term after-tax efficiency and proper account placement.
If helpful, feel free to answer at a category level (e.g., “U.S. dividend aristocrats,” “Canadian compounders,” etc.) or with specific examples you think are particularly well-suited.
Thanks — looking forward to your thoughts.
-
QUALCOMM Incorporated (QCOM $156.37)
- $156.37 P/E (TTM): 30.75X Cap: $167.47B
- View QCOM Profile
- View Questions on QCOM
-
AbbVie Inc. (ABBV $216.15)
- $216.15 P/E (TTM): 163.39X Cap: $382.02B
- View ABBV Profile
- View Questions on ABBV
-
Altria Group Inc. (MO $61.08)
- $61.08 P/E (TTM): 11.67X Cap: $102.65B
- View MO Profile
- View Questions on MO
-
Procter & Gamble Company (The) (PG $146.06)
- $146.06 P/E (TTM): 21.46X Cap: $341.30B
- View PG Profile
- View Questions on PG
-
Williams Companies Inc. (The) (WMB $63.18)
- $63.18 P/E (TTM): 31.87X Cap: $75.11B
- View WMB Profile
- View Questions on WMB
-
Exxon Mobil Corporation (XOM $133.61)
- $133.61 P/E (TTM): 18.96X Cap: $550.17B
- View XOM Profile
- View Questions on XOM
Q: Hi, I’m looking to create a portfolio of dividend growth stocks split over Canada and Us stocks with 10-12 names. Can you make a recommendation on the names you would use?
Insiders
Share Information
SEC Filings
News and Media